Prohibiting Abortion Industry’s Lucrative Loopholes Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
65pct
7d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
Prohibiting Abortion Industry's Lucrative Loopholes Act This bill expands the prohibition on the sale or purchase of human fetal tissue in interstate commerce to include any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of such tissue.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2023 · first_quarter · Taxation/Internal Revenue Code
S. 74 Providing for Life Act; H.R. 416 Prohibiting Abortion Industrys Lucrative Loopholes Act; H.R. 1126 HOPE Act
Client expense: $300,000 · Firm income: Not reported
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Family issues/Abortion/Adoption
Equal Rights Amendment; Protecting Pain-Capable Unborn Child from Late-Term Abortions; H.R. 12, S. 701 Womens Health Protection Act of 2023; H.R. 26, S. 204 Born-Alive Abortion Survivors Protection Act; H.R. 792, S.78 Child Interstate Abortion Notification Act; Veterans Affairs Reproductive Health Services Interim Final Rule; S. 74 Providing for Life Act; H.R. 175 Heartbeat Protection Act of 2023; H.R. 427, S. 95 Support and Value Expectant Moms and Babies Act; Chemical abortion; Congressional Actions against pro-abortion political violence; H.R. 279 Pharmacist Conscience Protection Act; H.R. 1771 Pregnancy Resource Center Defense Act; H.R. 384 Protecting Life from Chemical Abortions Act; H.R. 1297 To amend title 10, United States Code, to restrict the Secretary of Defense from paying or reimbursing expenses relating to abortion services; H.R. 7, S. 62 No Taxpayer Funding for Abortion Act and Abortion Insurance Full Disclosure Act of 2023; H.R. 398 Protecting Life and Integrity Research Act; H.R. 471, S. 1074 Women's Public Health and Safety Act; H.Con.Res. 3 Expressing the sense of the House of Representatives condemning the recent attacks on pro-life facilities, groups, and churches; H.R. 461, S.18 Protect Individuals with Down Syndrome from Selective Abortion Act; S.959 Stopping Traffickers and Their Accomplices Act; H.R. 437 Reporting Accountability and Abuse Prevention Act; H.R. Resolution 48 Resolution expressing support for the Dobbs decision; H.R. 416 Prohibiting Abortion Industrys Lucrative Loopholes Act; H.R. 383 Nullify FDA REMS change; H.R. 421 Teleabortion Prevention Act; H.R. 435 Protecting Life on College Campus Act of 2023; S.Res. 10, H.Res. 52 Day of Tears Resolution; S.76, H.R. 517 Standing with Moms Act; S. 166 HEALING Mothers and Fathers Act; H.R. 862 Dismemberment Abortion Ban Act; H.R. 632, S. 15 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023; S. 197 American Values Act; H.R. 983 Second Chance at Life Act; H.R. 1470 No Federal Funds for Abortion Travel Expenses Act; H.R. 1126 HOPE Act; S. 1102 Dignity for Aborted Children Act; S. 822 Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act; Holds on DOD confirmations and promotions.
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2023 · first_quarter · Science/Technology
H.R. 398, Protecting Life and Integrity in Research Act; H.R. 416, Prohibiting Abortion Industry's Lucrative Loophole Act; H.R. 1466, Safe RESEARCH Act; S. 751, Human-Animal Chimera Prohibition Act; chimeric embryo research; fetal tissue research; validating a test for prion diseases; unproven cellular therapies
Client expense: $30,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| VA |
| Beth Van Duyne | Republican | TX |
| Bill Posey | Republican | FL |
| Bob Good | Republican | VA |
| Brad R. Wenstrup | Republican | OH |
| Brian Babin | Republican | TX |
| Debbie Lesko | Republican | AZ |
| Harold Rogers | Republican | KY |
| Jake Ellzey | Republican | TX |
| Jeff Duncan | Republican | SC |
| Jim Banks | Republican | IN |
| John H. Rutherford | Republican | FL |
| John R. Moolenaar | Republican | MI |
| Keith Self | Republican | TX |
| Michael Waltz | Republican | FL |
| Paul A. Gosar | Republican | AZ |
| Ralph Norman | Republican | SC |
| Randy K. Weber, Sr. | Republican | TX |
| Ronny Jackson | Republican | TX |